A review article of inflammatory bowel disease treatment and pharmacogenomics
Abstract Inflammatory bowel disease (IBD) involves a variety of conditions, particularly Crohn’s disease (CD) and ulcerative colitis (UC). IBD is characterized by chronic inflammatory process of patient’s gut. This review aims to summarize the pharmacogenetics of biologics approved for IBD and the c...
Main Authors: | Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-03-01
|
Series: | Beni-Suef University Journal of Basic and Applied Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43088-023-00361-0 |
Similar Items
-
Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients
by: Nashwa Eltantawy, et al.
Published: (2023-01-01) -
Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2022-12-01) -
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
by: Paula Zapata-Cobo, et al.
Published: (2023-08-01) -
Gene Identification in Inflammatory Bowel Disease via a Machine Learning Approach
by: Gerardo Alfonso Perez, et al.
Published: (2023-06-01) -
A Regional Survey of Awareness of Inflammatory Bowel Disease among the Saudi Population
by: Yaser Khalid Meeralam, et al.
Published: (2023-02-01)